Bibliographie
Developmental disorders of academic skills in children: the e‑cacy and safety of Tenoten for children in the multicenter double-blind placebo-controlled randomized study. Zavadenko N.N., Skripchenko N.V., Gaynetdinova D.D. et al. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2020; 120(9): 28–36. DOI: 10.17116/jnevro202012009128
Current possibilities in pharmacotherapy of anxiety disorders in children and adolescents. Zavadenko N.N., Simashkova N.V., Vakula I.N. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(11): 33‑39.
DOI: 10.17116/jnevro201511511133-39
Clinical and safety evaluation of Brillia patients with attention-decit/hyperactivity disorder, Allen and al., and al. – JO – Clinical and Medical Reports, 2019/01/01
Effects of Tenoten on Anxiety and Depression Disorders in Patients with Epilepsy, A. B. Delger, G. N. Avakyan, O. M. Oleinikova. Bulletin of Experimental Biology and Medicine. September 2012 ; Vol. 153, No. 5, pp. 660-663
The Use of Tenoten and Tenoten (Pediatric Formulation) as a Drug for Premedication in Adults and Children during Outpatients Dentist Visit. L. I. Larentsova, D. V. Lyubimova. Bulletin of Experimental Biology and Medicine, 2009 ; Vol. 148, Suppl. 1, pp. 88-90
Open, randomized, comparative clinical study on the efficacy and safety of using Tenoten, 2 tablets 5 times a day for 4 weeks, for the cessation of reactive anxiety-depressive disorders and for the prophylaxis of post-traumatic stress disorder. Internal clinical study report TT1071111-101.C. OOO “NPF “MATERIA MEDICA HOLDING” Rusia,Moscú, 2008 – 2010. Confidential document
Tenoten in the Therapy of Patients with Moderate Cognitive Impairment. S. A. Duma and S. V. Shishkin. Bulletin of Experimental Biology and Medicine, 2009 ; Vol. 148, Suppl. 1, pp. 103-106
Tenoten in the Therapy of Anxious Disturbances in Patients with Essential Hypertension and Coronary Heart Disease. N. P. Vanchakova and A. P. Popov, Bulletin of Experimental Biology and Medicine, 2009 ; Vol. 148, Suppl. 1, pp. 91-93
Randomized, double-blind, placebo-controlled clinical study on the efficacy and safety of using Tenoten, 2 tablets 5 times a day for 4 weeks, in the treatment of anxiety in patients with neurological disorders, . Internal clinical study report TT106152.1531-100.P OOO “NPF “MATERIA MEDICA HOLDING” Moscú, Rusia, 2009 – 2010. Confidential document.
